0
Deep & Emerging Tech·June 23, 2026·1 min read

FDA Drops Complaint Against Whoop’s Blood Pressure Tracking Tool

Share

The FDA backing off Whoop’s blood-pressure feature shows regulators are willing to revisit early calls as evidence and labeling improve. If you’re building AI-driven health metrics, treat this as room to negotiate—but also as a reminder to design for reversible decisions and feature gating when scrutiny arrives.